CHINA BOTULINUM TOXIN MARKET FORECAST 2023-2030
SCOPE OF THE REPORT
China Botulinum Toxin Market by Type (Type A Botulinum Toxin, Type B Botulinum Toxin) Market by User Demographic (Women, Men) Market by Application (Medical (Chronic Migraine, Muscle Spasm, Overactive Bladder, Hyperhidrosis, Other Medical Applications), Aesthetic (Crow’s Feet, Forehead Lines, Frown Lines/glabellar, Square Jaw/masseter, Other Aesthetic Applications)) Market by End-user (Specialty and Dermatology Clinics, Hospitals and Clinics, Other End-users)
REPORTS » PHARMACEUTICALS » CHINA BOTULINUM TOXIN MARKET FORECAST 2023-2030
MARKET OVERVIEW
The China botulinum toxin market is projected to generate $752.32 million in revenue by 2030, and is anticipated to grow with a 10.31% CAGR during the estimation period, 2023-2030.
In China, the demand for medical beauty treatments is increasing due to economic growth, rising incomes, and changing consumption habits. Botulinum toxin type A is commonly used for medical purposes such as treating adult blepharospasm, prosopospasm, and certain types of strabismus. The incidence of facial neuropathy is also rising in China, with more women seeking treatments for thinning their faces or reducing wrinkles.
In 2021, the medical aesthetics market in China amounted to $31.63 billion, which is still growing. However, some medical institutions and beauty salons have been found to use smuggled botulinum toxin type A products from countries like South Korea, France, and Germany. Although only Botox and Hengli are approved for sale in China, these smuggled products are easily available. It is crucial to ensure the safety and efficacy of such products, and the government should take strict measures to prevent their use. Despite the challenges, the growing demand for medical aesthetics treatments in China presents a significant opportunity for companies in this sector.
To Know More About This Report, Request a Free Sample Copy
The China botulinum toxin market segmentation analysis entails user application, end-user, demographic, and type. Market by user demographic includes women and men.
In recent years, there has been a rise in the number of men opting for cosmetic procedures, as per studies. While women still constitute a significant majority of patients, men have shown a consistent upward trend in opting for such procedures. The declining stigma surrounding cosmetic surgery, the wider availability of treatments, and the increasing affordability of these treatments have all contributed to this trend. Minimally invasive procedures that require little or no recovery time are especially popular among men, with botulinum toxin being one of the most widely used treatments in 2020.
The American Society of Plastic Surgeons reported that male patients underwent nearly 265,000 botulinum toxin treatments alone in 2020. These procedures are so popular among men that they have been named “Brotox.” The increasing desire for natural-looking results is another crucial consideration for men opting for minimally invasive procedures. These treatments typically require minimal aftercare, allowing patients to return to their daily routine quickly. The demand for minimally invasive cosmetic procedures is expected to continue rising among men in the coming years.
Leading players in the China botulinum toxin market include Lanzhou Institute of Biological Products Co Ltd, Daewoong Pharmaceutical Co Ltd, etc.
Lanzhou Institute of Biological Products Co Ltd, a leading Chinese biological products research institute, is renowned for its production, research, development, and operation of preventive products, therapeutic products, and diagnostic reagents, amongst other biological products. The company has a strong customer base, providing it with a competitive edge and strengthening its position in the industry. The company is committed to developing innovative solutions by integrating new technologies, catering to its customer’s demands and needs, and expanding its operations.
The company has six specialized research labs, including one pilot research lab, enabling the formation of unique scientific research subjects and directions. The company’s primary products include an oral live rotavirus vaccine, group A and group C meningococcal polysaccharide vaccine, and Haemophilus influenzae type b conjugate vaccine. The company has established cooperative relations with renowned research institutions worldwide, such as the United States, Japan, Italy, Britain, and Hong Kong. Lanzhou Institute of Biological Products Co Ltd is headquartered in Gansu, China.
Lanzhou Institute of Biological Products Co Ltd’s botulinum toxin type A injection contains crystalline botulinum toxin type A active ingredient, which, upon reconstitution with sodium chloride injection, turns into a colorless or light yellow clear liquid. The injection treats adult patients with blepharospasm, hemifacial spasm, certain strabismus, and moderate to severe frown lines caused by corrugator and procerus muscle activity.
REPORT SYNOPSIS
REPORT SCOPE | DETAILS |
---|---|
Market Forecast Years | 2023-2030 |
Base Year | 2022 |
Market Historical Years | 2018-2022 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Type, User Demographic, Application, and End-User |
Countries Analyzed | China |
Companies Analyzed | AbbVie Inc, Daewoong Pharmaceutical Co Ltd, Evolus Inc, Galderma, Lanzhou Institute of Biological Products Co Ltd |
TABLE OF CONTENT
RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
- MAJOR MARKET FINDINGS
- FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
- GROWING AWARENESS ABOUT ‘NOTOX’
- INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
MARKET DYNAMICS
- KEY DRIVERS
- SURGE IN DEMAND FOR AESTHETIC PROCEDURES
- RISING GERIATRIC POPULATION
- GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
- KEY RESTRAINTS
- CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
- LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
- KEY DRIVERS
KEY ANALYTICS
- KEY MARKET TRENDS
- PESTLE ANALYSIS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- GROWTH PROSPECT MAPPING FOR CHINA
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
MARKET BY TYPE
- TYPE A BOTULINUM TOXIN
- TYPE B BOTULINUM TOXIN
MARKET BY USER DEMOGRAPHIC
- WOMEN
- MEN
MARKET BY APPLICATION
- MEDICAL
- CHRONIC MIGRAINE
- MUSCLE SPASM
- OVERACTIVE BLADDER
- HYPERHIDROSIS
- OTHER MEDICAL APPLICATIONS
- AESTHETIC
- CROW’S FEET
- FOREHEAD LINES
- FROWN LINES/GLABELLAR
- SQUARE JAW/MASSETER
- OTHER AESTHETIC APPLICATIONS
- MEDICAL
MARKET BY END-USER
- SPECIALTY AND DERMATOLOGY CLINICS
- HOSPITALS AND CLINICS
- OTHER END-USERS
COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS
- BUSINESS EXPANSIONS
- COMPANY PROFILES
- ABBVIE
- COMPANY OVERVIEW
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- DAEWOONG PHARMACEUTICAL CO LTD
- COMPANY PROFILE
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- EVOLUS INC
- COMPANY OVERVIEW
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- GALDERMA
- COMPANY OVERVIEW
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
- COMPANY OVERVIEW
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- ABBVIE
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: CHINA MARKET SNAPSHOT – BOTULINUM TOXIN
TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 3: CHINA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: CHINA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 5: CHINA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: CHINA BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 7: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 9: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 11: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 13: CHINA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: CHINA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 15: CHINA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 16: KEY PLAYERS OPERATING IN CHINA BOTULINUM TOXIN MARKET
TABLE 17: LIST OF ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS
TABLE 20: LIST OF BUSINESS EXPANSIONS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 7: CHINA BOTULINUM TOXIN MARKET, BY TYPE A BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 8: CHINA BOTULINUM TOXIN MARKET, BY TYPE B BOTULINUM TOXIN, 2023-2030 (IN $ MILLION)
FIGURE 9: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY USER DEMOGRAPHIC, IN 2022
FIGURE 10: CHINA BOTULINUM TOXIN MARKET, BY WOMEN, 2023-2030 (IN $ MILLION)
FIGURE 11: CHINA BOTULINUM TOXIN MARKET, BY MEN, 2023-2030 (IN $ MILLION)
FIGURE 12: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 13: CHINA BOTULINUM TOXIN MARKET, BY MEDICAL, 2023-2030 (IN $ MILLION)
FIGURE 14: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY MEDICAL, IN 2022
FIGURE 15: CHINA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2023-2030 (IN $ MILLION)
FIGURE 16: CHINA BOTULINUM TOXIN MARKET, BY MUSCLE SPASM, 2023-2030 (IN $ MILLION)
FIGURE 17: CHINA BOTULINUM TOXIN MARKET, BY OVERACTIVE BLADDER, 2023-2030 (IN $ MILLION)
FIGURE 18: CHINA BOTULINUM TOXIN MARKET, BY HYPERHIDROSIS, 2023-2030 (IN $ MILLION)
FIGURE 19: CHINA BOTULINUM TOXIN MARKET, BY OTHER MEDICAL APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 20: CHINA BOTULINUM TOXIN MARKET, BY AESTHETIC, 2023-2030 (IN $ MILLION)
FIGURE 21: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY AESTHETIC, IN 2022
FIGURE 22: CHINA BOTULINUM TOXIN MARKET, BY CROW’S FEET, 2023-2030 (IN $ MILLION)
FIGURE 23: CHINA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2023-2030 (IN $ MILLION)
FIGURE 24: CHINA BOTULINUM TOXIN MARKET, BY FROWN LINES/GLABELLAR, 2023-2030 (IN $ MILLION)
FIGURE 25: CHINA BOTULINUM TOXIN MARKET, BY SQUARE JAW/MASSETER, 2023-2030 (IN $ MILLION)
FIGURE 26: CHINA BOTULINUM TOXIN MARKET, BY OTHER AESTHETIC APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 27: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 28: CHINA BOTULINUM TOXIN MARKET, BY SPECIALTY AND DERMATOLOGY CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 29: CHINA BOTULINUM TOXIN MARKET, BY HOSPITALS AND CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 30: CHINA BOTULINUM TOXIN MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FAQ’s
RELATED REPORTS
-
GLOBAL MULTIPLEX ASSAY MARKET FORECAST 2024-2032
-
GERMANY MULTIPLEX ASSAY MARKET FORECAST 2024-2032
-
INDIA MULTIPLEX ASSAY MARKET FORECAST 2024-2032
-
UNITED STATES MULTIPLEX ASSAY MARKET FORECAST 2024-2032
-
CHINA PRODUCTIVITY MANAGEMENT SOFTWARE MARKET FORECAST 2024-2032
-
UNITED KINGDOM PRODUCTIVITY MANAGEMENT SOFTWARE MARKET FORECAST 2024-2032
-
UNITED STATES PRODUCTIVITY MANAGEMENT SOFTWARE MARKET FORECAST 2024-2032
-
CHINA PORTABLE AIR PURIFIER MARKET FORECAST 2024-2032
-
UNITED KINGDOM PORTABLE AIR PURIFIER MARKET FORECAST 2024-2032
-
UNITED STATES PORTABLE AIR PURIFIER MARKET FORECAST 2024-2032